Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Recombinant IL1RAP (Nadunolimab Biosimilar) antibody

The Humanized Monoclonal anti-IL1RAP (Nadunolimab Biosimilar) antibody is suitable to detect IL1RAP (Nadunolimab Biosimilar) in samples from Human. It has been validated for FACS and ELISA.
Catalog No. ABIN7850347
$292.43
Plus shipping costs $50.00
Shipping to: United States
Delivery in 12 to 15 Business Days

Quick Overview for Recombinant IL1RAP (Nadunolimab Biosimilar) antibody (ABIN7850347)

Target

IL1RAP (Nadunolimab Biosimilar)

Antibody Type

Recombinant Antibody

Reactivity

Human

Host

  • 2
  • 1
Humanized

Clonality

  • 2
  • 1
Monoclonal

Conjugate

  • 2
  • 1
This IL1RAP (Nadunolimab Biosimilar) antibody is un-conjugated

Application

Flow Cytometry (FACS), ELISA

Grade

Research Grade
  • Purpose

    Anti-IL1RAP(nadunolimab biosimilar) mAb

    Isotype

    IgG1, kappa
  • Application Notes

    ELISA 1:5000-10000, Flow Cyt 1:100

    Comment

    Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Please see Certificate of Analysis for specific instructions of reconstitution.

    Buffer

    Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.

    Storage

    -20 °C,-80 °C

    Storage Comment

    Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized antibodies are shipped at ambient temperature.

    Expiry Date

    12 months
  • Target

    IL1RAP (Nadunolimab Biosimilar)

    Alternative Name

    nadunolimab Biosimilar

    Target Type

    Biosimilar

    Background

    Synonyms Target:IL1AP, C3orf13, IL1R3, IL-1R-3, IL-1R3
    Synonyms Antibody:CAN-04, CAN04

    UniProt

    Q9NPH3
You are here:
Chat with us!